洞察市场格局
解锁药品研发情报

400客服电话

  • 购买数据产品

    400-9696-311 转1

  • 定制咨询业务

    400-9696-311 转2

  • 数据与AI定制业务

    400-9696-311 转3

  • 商务合作及其他问题

    400-9696-311 转4

  • 投诉及建议

    400-9696-311 转5

医药数据查询

【ChiCTR2100050853】Xiaojuan Wan:请与我们联系上传伦理批件 A nurse-led peer support intervention in stroke survivors

基本信息
登记号

ChiCTR2100050853

试验状态

正在进行

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2021-09-05

临床申请受理号

/

靶点

/

适应症

卒中

试验通俗题目

Xiaojuan Wan:请与我们联系上传伦理批件 A nurse-led peer support intervention in stroke survivors

试验专业题目

Effects of a Nurse-led Peer Support Intervention on the psychosocial outcomes of stroke survivors: a randomized controlled trial

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

To evaluate the effectiveness of the NPSI on the psychosocial outcomes of stroke survivors. Objectives: The specific objectives of this RCT are: 1. To evaluate the effectiveness of NPSI on primary outcomes (social participation, participation self-efficacy) of stroke survivors. 2. To evaluate the effectiveness of NPSI on secondary outcomes (psychological distress, self-efficacy in managing the chronic condition, social support, disease stigma, quality of life) of stroke survivors. 3. To examine the processes that underpin a group NPSI and identify the possible mediating role of social support, self-efficacy, and disease stigma in the effects of the NPSI on psychosocial outcomes.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

其它

随机化

the participants will be allocated randomly to the NPSI group or a control group (1:1 ratio). Blocked randomization will be used with 4 or 6 as a block. The random number sequence will be generated by a research assistant not involving in the recruitment, intervention delivery and outcome assessment.

盲法

Not stated

试验项目经费来源

PhD student scholarship

试验范围

/

目标入组人数

60

实际入组人数

/

第一例入组时间

2021-03-01

试验终止时间

2022-12-01

是否属于一致性

/

入选标准

1. Have a clinical diagnosis of ischemic or hemorrhagic first-ever or recurrent stroke within five years prior to enrollment; 2. Aged more than 18 years; 3. Able to communicate meaningfully in Mandarin and provide informed consent.;

排除标准

1. Are not medically stable or with a terminal illness; 2. Diagnosis with a mental illness; 3. Have moderate or severe cognitive impairment and cannot participate meaningfully in the workshop sessions (e.g., Mini–Mental State Examination 20) 4. Do not have the physical capacity to travel to the workshop site even with someones help; 5. Are participating in another intervention research program; 6. Do not have a reasonable expectation that they will attend a program for 2h/week for up to 6 weeks.;

研究者信息
研究负责人姓名
请登录查看
试验机构

香港中文大學醫學院那打素護理學院

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

香港中文大學的其他临床试验

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用

市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测

3,065亿元
2026年Q1总销售额
6.14%(2026Q1)
TOP5企业市场份额
药品销售排行榜
查看完整数据
2025Q4医院化学药销售增速 *按市场份额排序
  • 1
    甲氨蝶呤注射液
  • 2
    克霉唑阴道乳膏
  • 3
    氯化钠注射液
核心能力
  • 医药市场销售数据分析 · 医院、实体药店、网上药店
  • 市场竞争格局分析(靶点、药品类型、ATC大类)
更多信息,请进入市场洞察中心查看